Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.

ABSTRACT:

SUBMITTER: Herbst RS 

PROVIDER: S-EPMC5847342 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature